EMEA-001417-PIP01-12-M04
Key facts
| Invented name |
Adenuric
|
| Active substance |
febuxostat
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0226/2018
|
| PIP number |
EMEA-001417-PIP01-12-M04
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Prevention of hyperuricaemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Menarini International Operations Luxembourg S.A.
E-mail: prijli@menarini.it |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|